Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Immunogen sequence: TMNPHDIVQD AIHNFSPAYQ QYTQQSTLEP GPTWRGGAHG LSRSHSLSGA RDNEKTLLLS SDDEF
Highest antigen sequence identity to the following orthologs: Mouse - 97%, Rat - 97%.
TMEM184B, also known as C22orf5, is a 407 amino acid multi-pass membrane protein and represents a novel gene in the activation of the MAPK signaling pathway. The gene encoding TMEM184B maps to human chromosome 22; mutations in several of the genes in chromosome 22 are involved in the development of autism, schizophrenia, Phelan-McDermid syndrome and Neurofibromatosis type 2, suggesting that TMEM184B may play a role in these syndromes.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: CTA-447C4.2; Putative MAPK-activating protein FM08; Transmembrane protein 184B
基因别名: C22orf5; FM08; HS5O6A; HSPC256; PSEC0108; TMEM184B
UniProt ID: (Human) Q9Y519
Entrez Gene ID: (Human) 25829